MAB1692
Anti-Dystrophin Antibody, mid-rod, clone 6D3
culture supernatant, clone 6D3, Chemicon®
Synonym(s):
Anti-BMD, Anti-CMD3B, Anti-DXS142, Anti-DXS164, Anti-DXS206, Anti-DXS230, Anti-DXS239, Anti-DXS268, Anti-DXS269, Anti-DXS270, Anti-DXS272, Anti-MRX85
Sign Into View Organizational & Contract Pricing
All Photos(3)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
biological source
mouse
Quality Level
antibody form
culture supernatant
antibody product type
primary antibodies
clone
6D3, monoclonal
species reactivity
mouse, canine, human, rabbit, rat
manufacturer/tradename
Chemicon®
technique(s)
immunohistochemistry: suitable
western blot: suitable
isotype
IgG2a
NCBI accession no.
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Gene Information
human ... DMD(1756)
Specificity
Mid rod domain (between amino acids 1181 and 1388) of human dystrophin. Also reacts with skeletal, cardiac and smooth muscle dystrophin from normal mouse, rat, rabbit and dog. Other animal species have not been tested. Reacts on blots with the brain isoform. No reactivity with mdx mouse tissue or DMD/BMD patients who have a gene deletion which removes the antibody binding site. Does not react with chicken dystrophin.
STAINING PATTERN:Light microscopy: continuous rim of labeling at the periphery of muscle fibers.
E.M. gold: close to the cytoplasmic face of the plasma membrane.
Western blotting: strong double bands at approximately 400 kD plus metabolites of lower molecular mass.
STAINING PATTERN:Light microscopy: continuous rim of labeling at the periphery of muscle fibers.
E.M. gold: close to the cytoplasmic face of the plasma membrane.
Western blotting: strong double bands at approximately 400 kD plus metabolites of lower molecular mass.
Immunogen
Bacterial fusion protein (Cell (1987) 51:919-928).
Epitope: mid-rod
Application
Immunohistochemistry: (fresh frozen, unfixed tissue only): use
undiluted - 1:20. Not recommended for use on paraffin embedded tissue.
EM Gold (Light fixation with 2% formaldehyde + 0.001% glutaraldehyde for 1 hour. 2.3M sucrose used as cryoprotectant.): use undiluted. 90 minute incubation at 25°C.
Western blotting: use 1:100-1:250.
Optimal working dilutions must be determined by the end user.
Protocol for Immunohistochemical use of MAB1692
1) Freeze muscle blocks in isopentane chilled in liquid nitrogen.
2) Cut 4 μm to 10 μm sections and air dry on slides coated with 0.5% gelatin containing 0.05% chrome alum.
3) Slides may be stored at -70 °C wrapped in cling film until required. If stored sections are used, allow sections to equilibrate to room temperature before unwrapping and proceeding.
4) Apply a 50 μL aliquot of primary antibody to sections (unfixed). Incubate for 1 hour at room temperature or 37°C.
5) Wash sections 3 x 10 minutes in phosphate buffered saline.
6) Apply a 50 μL aliquot of labeled second antibody. Incubate for 60 minutes at 25°C.
7) Wash sections 3 x 10 minutes in phosphate buffered saline.
8) Mount fluorescent sections in aqueous mounting media or visualize peroxidase label (DAB). Dehydrate, clean and mount peroxidase labeled sections for permanent preparations.
undiluted - 1:20. Not recommended for use on paraffin embedded tissue.
EM Gold (Light fixation with 2% formaldehyde + 0.001% glutaraldehyde for 1 hour. 2.3M sucrose used as cryoprotectant.): use undiluted. 90 minute incubation at 25°C.
Western blotting: use 1:100-1:250.
Optimal working dilutions must be determined by the end user.
Protocol for Immunohistochemical use of MAB1692
1) Freeze muscle blocks in isopentane chilled in liquid nitrogen.
2) Cut 4 μm to 10 μm sections and air dry on slides coated with 0.5% gelatin containing 0.05% chrome alum.
3) Slides may be stored at -70 °C wrapped in cling film until required. If stored sections are used, allow sections to equilibrate to room temperature before unwrapping and proceeding.
4) Apply a 50 μL aliquot of primary antibody to sections (unfixed). Incubate for 1 hour at room temperature or 37°C.
5) Wash sections 3 x 10 minutes in phosphate buffered saline.
6) Apply a 50 μL aliquot of labeled second antibody. Incubate for 60 minutes at 25°C.
7) Wash sections 3 x 10 minutes in phosphate buffered saline.
8) Mount fluorescent sections in aqueous mounting media or visualize peroxidase label (DAB). Dehydrate, clean and mount peroxidase labeled sections for permanent preparations.
Research Category
Metabolism
Metabolism
Research Sub Category
Muscle Physiology
Muscle Physiology
This Anti-Dystrophin Antibody, mid-rod, clone 6D3 is validated for use in WB, IH for the detection of Dystrophin.
Physical form
Culture supernatant, liquid in PBS with 1% BSA, containing 15 mM sodium azide.
Storage and Stability
Maintain at -20°C for up to one year in convenient undiluted aliquots. Avoid repeated freeze/thaw cycles.
Analysis Note
Control
POSITIVE CONTROL: Snap frozen normal human or rat striated muscle.
POSITIVE CONTROL: Snap frozen normal human or rat striated muscle.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
recommended
Product No.
Description
Pricing
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders.
Daria Wojtal et al.
American journal of human genetics, 98(1), 90-101 (2015-12-22)
Clustered regularly interspaced short palindromic repeat (CRISPR) has arisen as a frontrunner for efficient genome engineering. However, the potentially broad therapeutic implications are largely unexplored. Here, to investigate the therapeutic potential of CRISPR/Cas9 in a diverse set of genetic disorders
S Masuda et al.
Acta physiologica (Oxford, England), 195(4), 483-494 (2008-12-02)
The dystrophin-glycoprotein complex (DGC) and focal adhesion complex (FAC) are transmembrane structures in muscle fibres that link the intracellular cytoskeleton to the extracellular matrix. DGC and FAC proteins are abundant in slow-type muscles, indicating the structural reinforcement which play a
L Jensen et al.
BioMed research international, 2015, 265278-265278 (2015-04-09)
Trapezius myalgia is the most common type of chronic neck pain. While physical exercise reduces pain and improves muscle function, the underlying mechanisms remain unclear. Nitric oxide (NO) signaling is important in modulating cellular function, and a dysfunctional neuronal NO
beta-Dystroglycan binds caveolin-1 in smooth muscle: a functional role in caveolae distribution and Ca2+ release.
Sharma, P; Ghavami, S; Stelmack, GL; McNeill, KD; Mutawe, MM; Klonisch, T; Unruh, H; Halayko, AJ
Journal of Cell Science null
John Cw Hildyard et al.
PLoS currents, 8 (2016-08-16)
Exon-skipping via synthetic antisense oligonucleotides represents one of the most promising potential therapies for Duchenne muscular dystrophy (DMD), yet this approach is highly sequence-specific and thus each oligonucleotide is of benefit to only a subset of patients. The discovery that
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service